Molecules 2016, 21, 332
11 of 15
1-Ethyl 3-methyl 7-acetylindolizine-1,3-dicarboxylate (18). The reaction was performed with
6
(100 mg)
and ethyl propiolate in methanol, fol˝lowing method C. The indolizine 18 was obtained in 77% yield
(40 mg) as a red powder. mp 151–152 C; 1H-NMR (400 MHz, CDCl3)
δ 9.55 (m, 1H), 8.98 (m, 1H), 8.07
(s, 1H), 7.57 (dd, 1H, J = 7.4 Hz, 1.9 Hz), 5.34 (s, 2H), 4.46 (q, 2H, J = 7.2 Hz), 4.00 (s, 3H), 2.75 (s, 3H),
1.49 (t, 3H, J = 7.2 Hz); 13C-NMR (100 MHz, CDCl3)
δ 196.0, 163.8, 161.3, 137.5, 132.8, 127.6, 124.8, 121.4,
116.4, 111.8, 109.0, 60.4, 51.8, 26.1, 14.5; HRMS (ESI) m/z: [M + H]+ calcd for C15H16NO5 290.1023, obsd.
290.1022, [M + Na]+ calcd for C15H15NNaO5 312.0842, obsd. 312.0840.
1-Ethyl 3-methyl 7-(trifluoromethyl)indolizine-1,3-dicarboxylate (19a) and 1-methyl 3-methyl 7-(trifluoromethyl)
indolizine-1,3-dicarboxylate (19b). The reaction was performed with 4 (50 mg) and ethyl propiolate in
methanol, following method C. The mixture of indolizines 19a and 19b (30/70 ratio) was obtained in
1
55% yield (27 mg) as a yellow powder. H-NMR (400 MHz, CDCl3)
δ
9.60 (d, 1H, J = 7.2 Hz), 8.64 (s,
1H), 8.04 (s, 1H), 7.12 (dd, 1H, J = 7.2, 2.0 Hz), 4.40 (q, 2H, J = 7.2 Hz, CH2 of 19a), 3.95 and 3.94 (2s,
3H, OMe of 19a and 19b), 1.42 (t, 3H, J = 7.2 Hz, CH3 of 19a); 13C-NMR (100 MHz, CDCl3)
164.0,
163.5, 161.3, 136.8, 128.4,127.16, 125.7 (q, 225 Hz, CF3), 124.9, 124.6, 121.9, 117.5, 117.4, 116.1, 110.1,
2
ˆ
δ
107.9, 60.5, 51.8, 51.6, 14.5; HRMS (ESI) 19a : m/z calcd for C14H13F3NO4 316.0791, obsd 316.0796, 19b
m/z calcd for C13H11F3NO4 302.0635, obsd 302.0638.
:
1-Ethyl 3-methyl 7-cyanoindolizine-1,3-dicarboxylate (20). The reaction was performed with
7 (50 mg)
and ethyl propiolate in methanol, following method C. The indolizine 20 was obtained in 81% yield
˝
(37 mg) as a white powder. mp 114–115 C; 1H-NMR (400 MHz, CDCl3)
δ 9.58 (dd, 1H, J = 7.2, 0.8 Hz),
8.74–8.75 (m, 1H), 8.06 (s, 1H), 7.07 (dd, 1H, J = 7.2, 2.0 Hz), 4.42 (q, 1H, J = 7.0 Hz), 3.98 (s, 3H), 1.44
(t, 3H, J = 7.2 Hz); 13C-NMR (100 MHz, CDCl3)
δ 163.2, 161.1, 136.0, 128.2, 125.9, 125.1, 117.5, 114.1,
109.0, 108.0, 60.7, 52.0, 14.5; HRMS (ESI) m/z: [M + H]+ calcd for C14H13N2O4 273.0869, obsd 273.0870.
1,3-Diethyl 7-acetylindolizine-1,3-dicarboxylate (22) [61]. The reaction was performed with 12 (100 mg)
and ethyl propiolate, following method D. The indolizine 22 was obtained in 12% yield (9 mg) as a
white powder. mp 125–127 ˝C. 1H-NMR (400 MHz, DMSO-d6)
δ 9.47 (dd, 1H, J = 0.8, 7.4 Hz), 8.81
(d, 1H, J = 0.8 Hz), 7.90 (s, 1H), 7.62 (dd, 1H, J = 1.9, 7.4 Hz), 4.35–4.40 (m, 4H), 2.69 (s, 3H), 1.35–1.41
(m, 6H).
1,3-Diethyl 7-cyanoindolizine-1,3-dicarboxylate (23). The reaction was performed with 13 (15 mg) and
ethyl propiolate, following method D. The indolizine 23 was obtained in 40% yield (4.9 mg) as a white
˝
powder. mp 103–104 C; 1H-NMR (400 MHz, CDCl3) δ 9.64 (dd, 1H, J = 0.8, 7.2 Hz), 8.78 (s, 1H), 8.11
(s, 1H), 7.11 (dd, 1H, J = 1.6, 7.2 Hz), 4.45–4.50 (m, 4H), 1.46–1.51 (m, 6H); 13C-NMR (100 MHz, CDCl3)
δ
163.2, 161.1, 136.1, 128.2, 125.8, 125.0, 117.5, 116.9, 114.1, 109.0, 108.0, 61.4, 60.7, 52.0, 14.5 (identical to
the commercial compound).
1-Ethyl 3-benzoyl-7-cyanoindolizine-1-carboxylate (24). The reaction was performed with 8 (50 mg) and
ethyl propiolate in methanol, following m˝ethod C. The indolizine 24 was obtained in 50% yield
(22.4 mg) as an orange powder. mp 136–137 C; 1H-NMR (400 MHz, CDCl3)
δ 9.99 (d, 1H, J = 6.8 Hz),
8.83 (s, 1H), 7.95 (s, 1H), 7.87 (d, 2H, J = 6.8 Hz), 7.67 (d, 1H, J = 6.4 Hz), 7.60 (d, 2H, J = 7.2 Hz), 7.20
(d, 1H, J = 6.8 Hz), 4.47 (q, 2H, J = 7.2 Hz), 1.47 (t, 3H, J = 7.2 Hz); 13C-NMR (100 MHz, CDCl3)
δ
186.1,
163.2, 138.9, 136.9, 132.3, 129.3, 129.1, 129.0, 128.7, 128.4, 125.6, 124.2, 117.3, 114.8, 109.7, 109.4, 60.8,
14.53; HRMS (ESI) m/z calcd for C19H15N2O3 319.1077, obsd 319.1081.
1-Ethyl 3-(4-nitrobenzoyl)-7-cyanoindolizine-1-carboxylate (25). The reaction was performed with
and ethyl propiolate in methanol, following method C. The indolizine 25 was obtained in 67% yield
(29.6 mg) as a yellow powder. mp 143–144 ˝C; 1H-NMR (400 MHz, CDCl3)
9.92 (d, 1H, J = 7.2 Hz),
8.75 (s, 1H), 8.34 (d, 2H, J = 8.5 Hz), 7.90 (d, 2H, J = 8.4 Hz), 7.76 (s, 1H), 7.17 (m, 1H), 4.35 (q, 2H, J = 7.1
9 (50 mg)
δ
Hz), 1.35 (t, 3H, J = 7.1 Hz); 13C-NMR (100 MHz, CDCl3)
δ 183.9, 163.0, 150.0, 144.3, 137.7, 130.1, 129.9,
129.6, 129.3, 125.9, 124.1, 123.9, 123.6, 117.2, 115.7, 110.9, 110.2, 61.2, 14.7; HRMS (ESI) m/z: [M + H]+
calcd for C19H14N3O5 364.0927, obsd 364.0928.